deListed Australia
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:


ASX Announcements (courtesy of ASX)


ASX, Legal & CGT Status


(updated at weekends)
2021 2022 2023   ALL
Former (or subsequent) names
Shareholder links
Our website ranking of TSN: rating 2
(2 out of 5)


Link Market Services Brisbane
Level 21, 10 Eagle Street Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details
ISIN: AU0000182867
Address: Level 12, 680 George Street Sydney NSW 2000
Tel:  +61 (2) 8280 7355

Date first listed: 23/12/2003

Sector: Pharmaceuticals Biotechnology & Life Sciences
Industry Group: XHJ
Activities: Hemp growing and production services

delisted at entity's request under Listing Rule 17.11


we understand Elixinol Wellness was successful with an offer of 1.1225 Elixinol Wellness ordinary fully paid shares for each TSN share


The scheme of arrangement to effect the acquisition by Elixinol Wellness pursuant to which the Company will acquire 100% of the ordinary shares of The Sustainable Nutrition Group Ltd, that was approved by holders of TSN shares on 2 August 2023 and by the Federal Court of Australia on 7 August 2023, has today been implemented. Elixinol Wellness now holds all of the ordinary shares in TSN. Scheme Participants who held TSN shares as at 7:00pm (AEST) on 10 August 2023 have today been issued consideration of 1.1225 Elixinol Wellness ordinary fully paid shares for each Scheme Share. The consideration that would otherwise have been issued to Ineligible Shareholders under the Scheme has been issued to the Sale Nominee, in accordance with the Scheme.


The company releases a notification of cessation of securities.


The company releases a notice of application for quotation of securities.


The securities of The Sustainable Nutrition Group Ltd will be suspended from quotation at the close of trading today, Tuesday 8 August 2023, in accordance with Listing Rule 17.2, following lodgement of the Federal Court of Australia orders with ASIC approving the scheme of arrangement by which Elixiol Wellness will acquire all of the issued shares in TSN.


The suspension of trading in the securities of The Sustainable Nutrition Group Ltd will be lifted from the commencement of trading on Friday, 6 January 2023 following lodgement of its Annual Report, Appendix 4G and Corporate Governance Statement.


The company lodges the following: 2022 Annual Report, Appendix 4G and Corporate Governance Statement.


The company releases a notification regarding unquoted securities.


The company releases a notification of cessation of securities.


Elixinol Wellness to implement schemes of arrangement with The Sustainable Nutrition Group Ltd to acquire 100% of TSN's ordinary shares and effect an exchange of options. Acquisition increases size and scale for both Elixinol Wellness and TSN. Group to own and operate brands across four key verticals: plant-based food and nutrition, hemp-based nutraceuticals such as CBD, pet nutritional supplements and skin health. TSN brands include Australian Primary Hemp, Mt Elephant, Field Day and The Australian Superfood Company. Group is anticipated to benefit from potential annualised cost savings and identified synergies of up to $6.6m, including potential savings identified from the strategic reviews undertaken by both companies and identified potential synergies of up to $2.3m. Shared new product development, increased product range and IP to assist in driving growth across retail, wholesale and ecommerce channels. Acquisition enables the group to leverage access to the largest hemp farmer network in Australia and increased distribution points from 2,300 to 4,100 locations. Global plant-based protein market expected to significantly grow from US$10.3bn in 2020 to US$17.5bn in 2027.


Regarding the acquisition of The Australian Superfood Company, the acquisition price of A$3.0 million was to be paid as follows: A$1.85 million cash, which was paid in part settlement in late January 2022; and A$1.15 million in TSN fully paid ordinary shares to be paid upon TASCo achieving a Target Gross Profit of A$1.3 million in FY22. The Consideration Shares were to be issued at a price equivalent to the 10-day VWAP once the earn out criterion was met in June 2022.


The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.


10,354,284 unlisted options exercisable at $0.26 have expired in accordance with their terms of issue.The unlisted options were approved by shareholders at the Company's Annual General Meeting held on 16 September 2019 as part of the share sale agreement to the founders and advisers of the Company as announced on 21 June 2019.


The company releases a notification of cessation of securities.


The company lodges its Appendix 4E and Preliminary Final Report.


The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.


The company is continuing its voluntary suspension until the close of trading on 29 July 2022 in order to provide the company with additional time to continue its comprehensive strategic review of the company's product ranging, customer acquisition pipeline and financial forecasts following the loss of a strategic customer supply agreement for existing branded goods. The voluntary suspension is anticipated to remain in place until the earlier of the close of normal trading on 29 July 2022 or when the strategic review has been completed and the market update has been released.


The company extends the voluntary suspension of its securities until the close of trading on 30 June 2022, following the initial notice of voluntary suspension released on 18 May 2022.


The company releases a notification of cessation of securities.


The securities of The Sustainable Nutrition Group will be suspended from quotation immediately under Listing Rule 17.2, at the request of TSN, pending the release of an announcement regarding the termination of a key strategic customer supply agreement.


name changed from Australian Primary Hemp Limited

View ASX Announcements (courtesy of ASX)


Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

Con artists, Clearly as  their breeding was questionable

I wish I had the hindsiight to see this comming

You cannot make a work of art with carving Crap

10/06/2022 15:15:52
Company Updates
Post your comments here
Please read our Terms before posting comments.
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    30/12/2021James Hood247,455$0.196$48,520
    18/11/2019Charles Mann249,020$0.201$50,043
    14/11/2019Charles Mann5,151$0.180$927
    08/01/2018David Lamm48,550,000$0.016$798,309
    04/01/2018Darren Book256,659$0.021$5,447

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    Karun MosesCOO26/05/2022
    Pauline GatelyNon Exec Director02/10/2019
    Josephine LorenzDirector17/08/2023
    Ron DufficyDirector17/08/2023

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    Shane GildIndependent Director07/06/202117/08/2023
    Thomas SiebelIndependent Director21/10/202117/08/2023
    James HoodNon Exec Director02/10/201917/08/2023
    Neale JosephManaging Director, CEO13/03/202026/05/2022
    Cameron PetricevicNon Exec Director06/06/201807/06/2021
    Charles MannDirector, CEO02/10/201912/03/2020
    Lynden PolonskyDirector04/03/201902/10/2019
    Melanie LeydinDirector, CFO11/04/201602/10/2019
    Simon GennariNon Exec Chairman29/02/201604/03/2019
    Darren BookNon Exec Director12/12/201604/03/2019
    David LammNon Exec Director07/03/201606/06/2018
    Nathan DronaNon Exec Director22/03/201325/11/2016
    Tracie RamsdaleNon Exec Director09/07/200329/06/2016
    Jenni PilcherCFO01/09/201411/04/2016
    Ken PoutakidisNon Exec Chairman26/06/201529/02/2016
    Timothy HughesChairman15/07/201309/07/2015
    Santo CostaNon Exec Chairman01/03/201410/06/2015
    Susan KelleyNon Exec Director22/03/201310/06/2015
    Thomas LiquardCEO16/12/201311/11/2014
    Charles WalkerCEO24/02/2014
    Melvyn BridgesNon Exec Chairman02/10/200313/07/2013
    Nerolie WithnallDirector27/10/200304/07/2013
    Peter SmithCEO26/04/200725/01/2013
    Carlo MontagnerNon Exec Director07/03/200822/11/2011
    Peter AndrewsNon Exec Director02/11/199521/11/2008
    Julian ClarkNon Exec Director18/09/200621/11/2008
    Errol MaltaNon Exec Director27/10/200330/09/2007
    Kevin HealeyNon Exec Director12/03/199818/09/2006
    Nicholas MathiouAlternate Director01/08/2005

    Date of first appointment, title may have changed.